大腸処置の世界市場インサイト、2029年までの予測Global Colorectal Procedure Market Insights, Forecast to 2029 市場分析・洞察:バイオマーカー技術の世界市場 バイオマーカー技術の世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長すると予測されます。 バイオマーカ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場分析・洞察:バイオマーカー技術の世界市場バイオマーカー技術の世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長すると予測されます。 バイオマーカー技術の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年までの予測期間中にCAGR %で増加するとされています。 バイオマーカー技術の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中に年平均成長率(CAGR)%で増加する。 バイオマーカー技術のヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加する。 バイオマーカー技術の世界の主要企業は、Abbott Laboratories、Quanterix、Bio-Rad Laboratories、Epigenomics、Agilent Technologies、Johnson & Johnson、Qiagen、Roche Holding、Siemens Healthcareなど、2022年には世界の上位5社が収益面で約 %のシェアを占めていました。 レポートの内容 本レポートでは、バイオマーカー技術の世界市場規模を概観しています。2018年~2022年の過去の市場収益データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析が可能です。 バイオマーカー技術の主要生産者を調査し、主要地域と国の収益も提供します。バイオマーカー技術の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータをもとに、バイオマーカー技術の収益、主要企業の市場シェア、業界ランキングに焦点を当てています。世界のバイオマーカー技術市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づき分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業や市場戦略をより良い方法で位置づけるのに役立つと思われます。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、収益、成長率を分析しています。バイオマーカー技術の収益、予測される成長動向、生産技術、アプリケーション、エンドユーザー産業の市場規模を評価・予測します。 Abbott Laboratories、Quanterix、Bio-Rad Laboratories、Epigenomics、Agilent Technologies、Johnson & Johnson、Qiagen、Roche Holding、Siemens Healthcareなど、世界の主要プレイヤーの説明付き企業プロファイルを掲載。 会社別 アボット・ラボラトリーズ クオンタリックス バイオ・ラッド・ラボラトリーズ エピジェノミクス アジレント・テクノロジー ジョンソン・エンド・ジョンソン キアゲン ロシュ・ホールディング シーメンスヘルスケア ミリアドジェネティクス タイプ別セグメント ポリメラーゼ連鎖反応(PCR) 次世代シーケンサー(NGS) イムノアッセイ その他 アプリケーション別セグメント がん 感染症 自己免疫疾患 循環器系疾患 その他 地域別 北アメリカ 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 その他のヨーロッパ アジア・パシフィック 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア 中南米 メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ・中南米 トルコ サウジアラビア UAE MEAの残りの地域 各章の概要 第1章:報告書のスコープ、異なる市場セグメント(製品タイプ、アプリケーションなど)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介します。市場の現状と、短・中期・長期的にどのような進化を遂げる可能性があるのか、高いレベルの見解を示しています。 第2章 バイオマーカー技術の世界・地域レベルでの収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。 第3章:バイオマーカー技術企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、開発可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。 第6章:北米:タイプ別、アプリケーション別、国別、各セグメント別の収益。 第7章:ヨーロッパ:タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第8章:中国 タイプ別、アプリケーション別、セグメント別の収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメントごとの収益。 第10章 中東、アフリカ、中南米 タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第11章:主要企業のプロファイルを提供し、製品の説明や仕様、バイオマーカー技術の収益、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章 アナリストの視点/結論 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biomarker Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Polymerase Chain Reaction(PCR) 1.2.3 Next Generation Sequencing(NGS) 1.2.4 Immunoassay 1.2.5 Others 1.3 Market by Application 1.3.1 Global Biomarker Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Cancer 1.3.3 Infectious Diseases 1.3.4 Auoimmune Disorders 1.3.5 Cardiovascular Disorders 1.3.6 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Biomarker Technology Market Perspective (2018-2029) 2.2 Global Biomarker Technology Growth Trends by Region 2.2.1 Biomarker Technology Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Biomarker Technology Historic Market Size by Region (2018-2023) 2.2.3 Biomarker Technology Forecasted Market Size by Region (2024-2029) 2.3 Biomarker Technology Market Dynamics 2.3.1 Biomarker Technology Industry Trends 2.3.2 Biomarker Technology Market Drivers 2.3.3 Biomarker Technology Market Challenges 2.3.4 Biomarker Technology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Biomarker Technology by Players 3.1.1 Global Biomarker Technology Revenue by Players (2018-2023) 3.1.2 Global Biomarker Technology Revenue Market Share by Players (2018-2023) 3.2 Global Biomarker Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Biomarker Technology, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Biomarker Technology Market Concentration Ratio 3.4.1 Global Biomarker Technology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biomarker Technology Revenue in 2022 3.5 Global Key Players of Biomarker Technology Head office and Area Served 3.6 Global Key Players of Biomarker Technology, Product and Application 3.7 Global Key Players of Biomarker Technology, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Biomarker Technology Breakdown Data by Type 4.1 Global Biomarker Technology Historic Market Size by Type (2018-2023) 4.2 Global Biomarker Technology Forecasted Market Size by Type (2024-2029) 5 Biomarker Technology Breakdown Data by Application 5.1 Global Biomarker Technology Historic Market Size by Application (2018-2023) 5.2 Global Biomarker Technology Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Biomarker Technology Market Size (2018-2029) 6.2 North America Biomarker Technology Market Size by Type 6.2.1 North America Biomarker Technology Market Size by Type (2018-2023) 6.2.2 North America Biomarker Technology Market Size by Type (2024-2029) 6.2.3 North America Biomarker Technology Market Share by Type (2018-2029) 6.3 North America Biomarker Technology Market Size by Application 6.3.1 North America Biomarker Technology Market Size by Application (2018-2023) 6.3.2 North America Biomarker Technology Market Size by Application (2024-2029) 6.3.3 North America Biomarker Technology Market Share by Application (2018-2029) 6.4 North America Biomarker Technology Market Size by Country 6.4.1 North America Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Biomarker Technology Market Size by Country (2018-2023) 6.4.3 North America Biomarker Technology Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Biomarker Technology Market Size (2018-2029) 7.2 Europe Biomarker Technology Market Size by Type 7.2.1 Europe Biomarker Technology Market Size by Type (2018-2023) 7.2.2 Europe Biomarker Technology Market Size by Type (2024-2029) 7.2.3 Europe Biomarker Technology Market Share by Type (2018-2029) 7.3 Europe Biomarker Technology Market Size by Application 7.3.1 Europe Biomarker Technology Market Size by Application (2018-2023) 7.3.2 Europe Biomarker Technology Market Size by Application (2024-2029) 7.3.3 Europe Biomarker Technology Market Share by Application (2018-2029) 7.4 Europe Biomarker Technology Market Size by Country 7.4.1 Europe Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Biomarker Technology Market Size by Country (2018-2023) 7.4.3 Europe Biomarker Technology Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Biomarker Technology Market Size (2018-2029) 8.2 China Biomarker Technology Market Size by Type 8.2.1 China Biomarker Technology Market Size by Type (2018-2023) 8.2.2 China Biomarker Technology Market Size by Type (2024-2029) 8.2.3 China Biomarker Technology Market Share by Type (2018-2029) 8.3 China Biomarker Technology Market Size by Application 8.3.1 China Biomarker Technology Market Size by Application (2018-2023) 8.3.2 China Biomarker Technology Market Size by Application (2024-2029) 8.3.3 China Biomarker Technology Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Biomarker Technology Market Size (2018-2029) 9.2 Asia Biomarker Technology Market Size by Type 9.2.1 Asia Biomarker Technology Market Size by Type (2018-2023) 9.2.2 Asia Biomarker Technology Market Size by Type (2024-2029) 9.2.3 Asia Biomarker Technology Market Share by Type (2018-2029) 9.3 Asia Biomarker Technology Market Size by Application 9.3.1 Asia Biomarker Technology Market Size by Application (2018-2023) 9.3.2 Asia Biomarker Technology Market Size by Application (2024-2029) 9.3.3 Asia Biomarker Technology Market Share by Application (2018-2029) 9.4 Asia Biomarker Technology Market Size by Region 9.4.1 Asia Biomarker Technology Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Biomarker Technology Market Size by Region (2018-2023) 9.4.3 Asia Biomarker Technology Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Biomarker Technology Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type 10.2.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Biomarker Technology Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application 10.3.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Biomarker Technology Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country 10.4.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Biomarker Technology Introduction 11.1.4 Abbott Laboratories Revenue in Biomarker Technology Business (2018-2023) 11.1.5 Abbott Laboratories Recent Developments 11.2 Quanterix 11.2.1 Quanterix Company Details 11.2.2 Quanterix Business Overview 11.2.3 Quanterix Biomarker Technology Introduction 11.2.4 Quanterix Revenue in Biomarker Technology Business (2018-2023) 11.2.5 Quanterix Recent Developments 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Details 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Biomarker Technology Introduction 11.3.4 Bio-Rad Laboratories Revenue in Biomarker Technology Business (2018-2023) 11.3.5 Bio-Rad Laboratories Recent Developments 11.4 Epigenomics 11.4.1 Epigenomics Company Details 11.4.2 Epigenomics Business Overview 11.4.3 Epigenomics Biomarker Technology Introduction 11.4.4 Epigenomics Revenue in Biomarker Technology Business (2018-2023) 11.4.5 Epigenomics Recent Developments 11.5 Agilent Technologies 11.5.1 Agilent Technologies Company Details 11.5.2 Agilent Technologies Business Overview 11.5.3 Agilent Technologies Biomarker Technology Introduction 11.5.4 Agilent Technologies Revenue in Biomarker Technology Business (2018-2023) 11.5.5 Agilent Technologies Recent Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Details 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Biomarker Technology Introduction 11.6.4 Johnson & Johnson Revenue in Biomarker Technology Business (2018-2023) 11.6.5 Johnson & Johnson Recent Developments 11.7 Qiagen 11.7.1 Qiagen Company Details 11.7.2 Qiagen Business Overview 11.7.3 Qiagen Biomarker Technology Introduction 11.7.4 Qiagen Revenue in Biomarker Technology Business (2018-2023) 11.7.5 Qiagen Recent Developments 11.8 Roche Holding 11.8.1 Roche Holding Company Details 11.8.2 Roche Holding Business Overview 11.8.3 Roche Holding Biomarker Technology Introduction 11.8.4 Roche Holding Revenue in Biomarker Technology Business (2018-2023) 11.8.5 Roche Holding Recent Developments 11.9 Siemens Healthcare 11.9.1 Siemens Healthcare Company Details 11.9.2 Siemens Healthcare Business Overview 11.9.3 Siemens Healthcare Biomarker Technology Introduction 11.9.4 Siemens Healthcare Revenue in Biomarker Technology Business (2018-2023) 11.9.5 Siemens Healthcare Recent Developments 11.10 Myriad Genetics 11.10.1 Myriad Genetics Company Details 11.10.2 Myriad Genetics Business Overview 11.10.3 Myriad Genetics Biomarker Technology Introduction 11.10.4 Myriad Genetics Revenue in Biomarker Technology Business (2018-2023) 11.10.5 Myriad Genetics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMarket Analysis and Insights: Global Biomarker Technology Market Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biomarker Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Polymerase Chain Reaction(PCR) 1.2.3 Next Generation Sequencing(NGS) 1.2.4 Immunoassay 1.2.5 Others 1.3 Market by Application 1.3.1 Global Biomarker Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Cancer 1.3.3 Infectious Diseases 1.3.4 Auoimmune Disorders 1.3.5 Cardiovascular Disorders 1.3.6 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Biomarker Technology Market Perspective (2018-2029) 2.2 Global Biomarker Technology Growth Trends by Region 2.2.1 Biomarker Technology Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Biomarker Technology Historic Market Size by Region (2018-2023) 2.2.3 Biomarker Technology Forecasted Market Size by Region (2024-2029) 2.3 Biomarker Technology Market Dynamics 2.3.1 Biomarker Technology Industry Trends 2.3.2 Biomarker Technology Market Drivers 2.3.3 Biomarker Technology Market Challenges 2.3.4 Biomarker Technology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Biomarker Technology by Players 3.1.1 Global Biomarker Technology Revenue by Players (2018-2023) 3.1.2 Global Biomarker Technology Revenue Market Share by Players (2018-2023) 3.2 Global Biomarker Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Biomarker Technology, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Biomarker Technology Market Concentration Ratio 3.4.1 Global Biomarker Technology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biomarker Technology Revenue in 2022 3.5 Global Key Players of Biomarker Technology Head office and Area Served 3.6 Global Key Players of Biomarker Technology, Product and Application 3.7 Global Key Players of Biomarker Technology, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Biomarker Technology Breakdown Data by Type 4.1 Global Biomarker Technology Historic Market Size by Type (2018-2023) 4.2 Global Biomarker Technology Forecasted Market Size by Type (2024-2029) 5 Biomarker Technology Breakdown Data by Application 5.1 Global Biomarker Technology Historic Market Size by Application (2018-2023) 5.2 Global Biomarker Technology Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Biomarker Technology Market Size (2018-2029) 6.2 North America Biomarker Technology Market Size by Type 6.2.1 North America Biomarker Technology Market Size by Type (2018-2023) 6.2.2 North America Biomarker Technology Market Size by Type (2024-2029) 6.2.3 North America Biomarker Technology Market Share by Type (2018-2029) 6.3 North America Biomarker Technology Market Size by Application 6.3.1 North America Biomarker Technology Market Size by Application (2018-2023) 6.3.2 North America Biomarker Technology Market Size by Application (2024-2029) 6.3.3 North America Biomarker Technology Market Share by Application (2018-2029) 6.4 North America Biomarker Technology Market Size by Country 6.4.1 North America Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Biomarker Technology Market Size by Country (2018-2023) 6.4.3 North America Biomarker Technology Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Biomarker Technology Market Size (2018-2029) 7.2 Europe Biomarker Technology Market Size by Type 7.2.1 Europe Biomarker Technology Market Size by Type (2018-2023) 7.2.2 Europe Biomarker Technology Market Size by Type (2024-2029) 7.2.3 Europe Biomarker Technology Market Share by Type (2018-2029) 7.3 Europe Biomarker Technology Market Size by Application 7.3.1 Europe Biomarker Technology Market Size by Application (2018-2023) 7.3.2 Europe Biomarker Technology Market Size by Application (2024-2029) 7.3.3 Europe Biomarker Technology Market Share by Application (2018-2029) 7.4 Europe Biomarker Technology Market Size by Country 7.4.1 Europe Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Biomarker Technology Market Size by Country (2018-2023) 7.4.3 Europe Biomarker Technology Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Biomarker Technology Market Size (2018-2029) 8.2 China Biomarker Technology Market Size by Type 8.2.1 China Biomarker Technology Market Size by Type (2018-2023) 8.2.2 China Biomarker Technology Market Size by Type (2024-2029) 8.2.3 China Biomarker Technology Market Share by Type (2018-2029) 8.3 China Biomarker Technology Market Size by Application 8.3.1 China Biomarker Technology Market Size by Application (2018-2023) 8.3.2 China Biomarker Technology Market Size by Application (2024-2029) 8.3.3 China Biomarker Technology Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Biomarker Technology Market Size (2018-2029) 9.2 Asia Biomarker Technology Market Size by Type 9.2.1 Asia Biomarker Technology Market Size by Type (2018-2023) 9.2.2 Asia Biomarker Technology Market Size by Type (2024-2029) 9.2.3 Asia Biomarker Technology Market Share by Type (2018-2029) 9.3 Asia Biomarker Technology Market Size by Application 9.3.1 Asia Biomarker Technology Market Size by Application (2018-2023) 9.3.2 Asia Biomarker Technology Market Size by Application (2024-2029) 9.3.3 Asia Biomarker Technology Market Share by Application (2018-2029) 9.4 Asia Biomarker Technology Market Size by Region 9.4.1 Asia Biomarker Technology Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Biomarker Technology Market Size by Region (2018-2023) 9.4.3 Asia Biomarker Technology Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Biomarker Technology Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type 10.2.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Biomarker Technology Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application 10.3.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Biomarker Technology Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country 10.4.1 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Biomarker Technology Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Biomarker Technology Introduction 11.1.4 Abbott Laboratories Revenue in Biomarker Technology Business (2018-2023) 11.1.5 Abbott Laboratories Recent Developments 11.2 Quanterix 11.2.1 Quanterix Company Details 11.2.2 Quanterix Business Overview 11.2.3 Quanterix Biomarker Technology Introduction 11.2.4 Quanterix Revenue in Biomarker Technology Business (2018-2023) 11.2.5 Quanterix Recent Developments 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Details 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Biomarker Technology Introduction 11.3.4 Bio-Rad Laboratories Revenue in Biomarker Technology Business (2018-2023) 11.3.5 Bio-Rad Laboratories Recent Developments 11.4 Epigenomics 11.4.1 Epigenomics Company Details 11.4.2 Epigenomics Business Overview 11.4.3 Epigenomics Biomarker Technology Introduction 11.4.4 Epigenomics Revenue in Biomarker Technology Business (2018-2023) 11.4.5 Epigenomics Recent Developments 11.5 Agilent Technologies 11.5.1 Agilent Technologies Company Details 11.5.2 Agilent Technologies Business Overview 11.5.3 Agilent Technologies Biomarker Technology Introduction 11.5.4 Agilent Technologies Revenue in Biomarker Technology Business (2018-2023) 11.5.5 Agilent Technologies Recent Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Details 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Biomarker Technology Introduction 11.6.4 Johnson & Johnson Revenue in Biomarker Technology Business (2018-2023) 11.6.5 Johnson & Johnson Recent Developments 11.7 Qiagen 11.7.1 Qiagen Company Details 11.7.2 Qiagen Business Overview 11.7.3 Qiagen Biomarker Technology Introduction 11.7.4 Qiagen Revenue in Biomarker Technology Business (2018-2023) 11.7.5 Qiagen Recent Developments 11.8 Roche Holding 11.8.1 Roche Holding Company Details 11.8.2 Roche Holding Business Overview 11.8.3 Roche Holding Biomarker Technology Introduction 11.8.4 Roche Holding Revenue in Biomarker Technology Business (2018-2023) 11.8.5 Roche Holding Recent Developments 11.9 Siemens Healthcare 11.9.1 Siemens Healthcare Company Details 11.9.2 Siemens Healthcare Business Overview 11.9.3 Siemens Healthcare Biomarker Technology Introduction 11.9.4 Siemens Healthcare Revenue in Biomarker Technology Business (2018-2023) 11.9.5 Siemens Healthcare Recent Developments 11.10 Myriad Genetics 11.10.1 Myriad Genetics Company Details 11.10.2 Myriad Genetics Business Overview 11.10.3 Myriad Genetics Biomarker Technology Introduction 11.10.4 Myriad Genetics Revenue in Biomarker Technology Business (2018-2023) 11.10.5 Myriad Genetics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|